Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View

The current standard medical therapy for atopic dermatitis (AD) mainly focuses on symptomatic relief by controlling skin inflammation with topical corticosteroids and/or topical calcineurin inhibitors. However, the clinical efficacy of pharmacological therapy is often disappointing to both patients...

Descripción completa

Detalles Bibliográficos
Autor principal: Nahm, Dong-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530142/
https://www.ncbi.nlm.nih.gov/pubmed/26273148
http://dx.doi.org/10.5021/ad.2015.27.4.355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530142/
https://www.ncbi.nlm.nih.gov/pubmed/26273148
http://dx.doi.org/10.5021/ad.2015.27.4.355

Ejemplares similares